Cargando…
A Green Light for Stop Mutations
Autores principales: | Cohen-Cymberknoh, Malena, Slae, Mordechai, Wilschanski, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Thoracic Society
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8086040/ https://www.ncbi.nlm.nih.gov/pubmed/33705685 http://dx.doi.org/10.1165/rcmb.2021-0060ED |
Ejemplares similares
-
Sa1067: INTERNATIONAL SURVEY ON SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 AND ACUTE PANCREATITIS CO-OCCURRENCE IN CHILDREN
por: Wilschanski, Michael, et al.
Publicado: (2022) -
Ivacaftor in People with Cystic Fibrosis and a 3849+10kb C→T or D1152H Residual Function Mutation
por: Kerem, Eitan, et al.
Publicado: (2021) -
Class 1 CF Mutations
por: Wilschanski, Michael
Publicado: (2012) -
THU279 Long duration Of CFTR Modulators Consistently Improve Glucose Metabolism Parameters In Patients With Cystic Fibrosis
por: Cohen, Amitay, et al.
Publicado: (2023) -
Stop
Publicado: (1877)